Graft Versus Host Disease Market to Reach $10.4 Bn, Globally, by 2031 at 13.5% CAGR: Allied Market Research

News provided by

Jul 14, 2022, 08:50 ET

Surge in geriatric population and an increase in the prevalence of nephrological, leukemia, myeloma, and lymphoma cancer drive the global graft versus host disease market.

PORTLAND, Ore., July 14, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, 'Graft Versus Host Disease Market by Product Type (Corticosteroids, Monoclonal antibodies, Immunosuppressants, Others), by Treatment Type (Acute GVHD, Chronic GVHD), by End Use (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031.' According to the report, the global graft versus host disease industry was estimated at $3.0 billion in 2021, and is anticipated to hit $10.4 billion by 2031, registering a CAGR of 13.5% from 2022 to 2031.

Prime determinants of growth-

Surge in geriatric population and increase in the prevalence of nephrological, leukemia, myeloma, and lymphoma cancer drive the global graft versus host disease market. Furthermore, rise in number of bone marrow transplants being carried around the globe to treat specific types of cancers has supplemented the growth even more. Simultaneously, rise in the GVHD-prevalent population, advancements in the diagnostic measures of the disease, approval of novel treatments, and a greater range of prophylaxis options are expected to create lucrative opportunities in the industry.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/12294

Covid-19 scenario-

A sharp decline in the number of transplantation procedures.
The fact that it requires the routine use of reusable equipment with close contact with patients impacted the global graft versus host disease market negatively, especially during the initial period.
However, the market has already gotten back on track.

Get detailed COVID-19 impact analysis on the Graft Versus Host Disease Market- https://www.alliedmarketresearch.com/request-for-customization/12294?reqfor=covid

The Acute GVHD segment to dominate by 2031-

By treatment type, the acute GVHD segment contributed to nearly three-fifths of the global graft versus host disease market share in 2021, and is expected to lead the trail by 2031. The same segment is also expected to exhibit the fastest CAGR of 5.8% from 2022 to 2031. Rise in the geriatric population coupled with increase in number of allogeneic transplantations drive the segment growth.

The hospitals pharmacies segment to maintain the lion's share-

By end-use, the hospitals pharmacies segment accounted for more than two-fifths of the global graft versus host disease market revenue in 2021, and will dominate by 2031, due to surge in demand for transplantation drugs. At the same time, the online pharmacies segment would manifest the fastest CAGR of 14.0% during the forecast period, owing to the Covid-19 pandemic in which the buying pattern of most of the individuals has changed to online pharmacies.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/12294

North America garnered the major share in 2021-

By region, North America garnered the major share in 2021, holding more than two-fifths of the global graft versus host disease market. This is attributed to increase in the number of organ donations of deceased persons for transplantation, rise in allogenic transplantation procedure, and surge in cancer patients in this province. Simultaneously, Asia-Pacific would cite the fastest CAGR of 15.9% throughout the forecast period, due to increase in demand for drugs such as corticosteroids and monoclonal antibodies across the region.

Key players in the industry-

Asahi Kasei
AbbVie
Bristol Myer Squibb
GlaxoSmithKline PLC
Sanofi.
Incyte Corporation
Pfizer
Accord Healthcare Limited
Merck & Co
Novartis

Official Press Release- https://www.alliedmarketresearch.com/press-release/graft-versus-host-disease-market.html

Similar Research Reports for Information, Communication and Technology:

Internet of Things in Healthcare Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Medical Tourism Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

3D Cell Culture Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Neurovascular Devices Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Viral Vector and Plasmid DNA Manufacturing Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com